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Similarities and Differences between the Effects of
Epidermal Growth Factor and Rous Sarcoma Virus
The epidermal growth factor (EGF) receptor protein and the
transforming proteins of at least four groups of RNA tumor
viruses have associated protein kinase activity . These protein
kinases are unusual in their strict specificity for tyrosine (1-
10) . This similarity and the fact that both EGF and tumor
viruses can stimulate cell growth suggest that characterization
of the protein kinasesand identification oftheir substrates may
help us understand themechanism ofgrowth control in normal
and transformed cells.
The activity of tyrosine protein kinases can be measured in
vitro with partially purified enzymes and added substrates, or
in vivo where the action of the virus-associated or EGF-stim-
ulated kinases may be observed as an increase in the net level
of phosphotyrosine in cellular proteins. Cells transformed by
Rous sarcoma virus, Abelson murine leukemia virus, feline
sarcomavirus (Snyder-Theilen and Gardner-Arnstein strains),
or the defective avian sarcoma viruses, Fujinami, PRCII, and
Y73, have high levels ofphosphotyrosine (6, 11-14) . The effects
ofEGF on tyrosine phosphorylation are best demonstrated in
a particular human tumor cell line, A431, which possesses a
high level of EGF receptors . The level of phosphotyrosine
increases three to four times within minutes of adding EGF
(15) . In the other cell types tested (3T3, HeLa), the increase is
much lower, possibly because ofthe lower number of receptors
in these cells. More detailed analysis, using a two-dimensional
gel procedure that aids in the detection of proteins containing
phosphotyrosine, has shown that the aforementioned viruses
induce phosphorylation of membersof the same set of cellular
proteins, although quantitative differences exist (16, 17) . At
least one of the proteins phosphorylated in human A431 cells
in response to EGF is homologous to one of the transformed
cell phosphoproteins, as shown by peptide mapping of their
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ABSTRACT
￿
We have derived a line of A431 human tumor cells infected with Rous sarcoma virus (RSV) .
The infected cells contain the RSV-transforming protein, pp60", which has characteristic tyrosine-
specific protein kinase activity . As in other RSV-transformed cells, a 36,000-dalton protein is phos-
phorylated in RSV-infected A431 cells . Addition of epidermal growth factor (EGF) to the cells induces
further phosphorylation of this protein . In contrast, this phosphoprotein is not detected in uninfected
A431 cells, except when treated with EGF . Increased phosphorylation of the EGF receptor protein and
of an 81,000-dalton cellular protein is dependent upon addition of EGF to the culture fluids, in both
control and RSV-infected A431 cells . The results are discussed with reference to the similarities and
differences between the tyrosine-specific protein kinases induced by RSV and activated by EGF.
nonphosphorylated forms (15) . While we find its molecular
weight to be 39,000, for clarity we will refer to this protein by
its original molecular weight designation, 36K (16-21) . One
other protein (81K), whose phosphorylation on serine and
tyrosine in A431 cells is EGF dependent (15), appears not to
be phosphorylated in RSV-transformed mouse cells (17), but
it is quite possible that the human protein is homologous to a
mouse protein of different size or isoelectric point .
To explore further the similarities and differences between
the effects mediated by EGF and by tumor viruses, we have
derived a line (SRA431) of A431 cells infected with Rous
sarcoma virus (RSV) and present here a preliminary charac-
terization of its phosphoproteins .
MATERIALS AND METHODS
4,431 cells were obtained from (: Tnaarn (National Institutes of Health,
Bethesda, Md .) (22) and grown in Dulbecco's modified Eagle's medium (DME)
with 10% calf serum. They were infected with Schmidt-Ruppin strain RSV,
subgroup D (gift of L . Rorschneider [Fred Hutchinson Cancer Research Center,
Seattle, Wash .)) by the method of Kawai (23). Subconfluent cells were overlaid
with l ml ofculture fluids from RSV-infectedchick cells for90 min at 37°C . The
fluids were replaced with l ml 40% vol/vol polyethylene glycol 1500 (BDH
Chemicals Ltd., Poole, England) for l min at 25°C. This was slowly diluted to a
final volume of 4.5 ml and removed after 10 min. Surviving cells were grown in
liquid culture for 17 d and then transferred to soft agar (24) . Uninfected A431
cells, like most tumor cells, do grow in soft agar but poorly at low cell densities
(24). Several particularly large colonies were picked from a 50-mm dish 4 wk
after seeding with 10 3 infected cells . The infected cells were maintained under the
same conditions as the parental cells .
Immune complex kinase assay for pp60"` was done as described (25) . Extract
from 1.6 x 10" cells was clarified and incubated with excess (5 ul) of normal
rabbit or tumor-bearing baby rabbit serum at 0°C in 150 pl of buffer (25)
containing 2 mM EDTA . Antibody was adsorbed to 1 mg of Pansorbin (Calbi-
ochem-Behring Corp ., San Diego, Calif .), and the complexes were washed
repeatedly (25) before incubation with 5 tLCi of [y-' zP]ATP, in 10 lal of 20 mM
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chainswere purified bygelelectrophoresis and Cerenkov radiation was measured.
EGF binding was determined essentially as described (26, 27) .
EGF additions to A431 andSRA431 cells were performed with subconfluent
cultures, because we had found earlier that A431 cells only showed phosphoryl-
ation changes in response to EGFwhen cultured at low density (15) . Cell cultures
were labeled with 0.6 mCi of["P]orthophosphate (carrier-free, ICN Pharmaceu-
ticals, Inc., Irvine, Calif) per ml ofphosphate-free DMEcontaining 4% complete
calfserum, for 12-18 h, to approach isotopicequilibrium .EGF (3 .31gM solution
in 0.1% serum albumin) wasadded as required to 10 nM final concentration, for
the last hour oflabeling . Thecultures were washed with cold Tris-buffered saline
and rapidly prepared forphosphoamino acid analysis (11) or for two-dimensional
gel electrophoresis (l6). Two-dimensional gels were run as before (15-17, 28)
with pH 6-8 ampholytes. They were incubated in alkali before autoradiography
(16) .
Membranes were partly purified from "P-labeled cells (mixed with unlabeled
carrier cells) by a scaled-down version ofa procedure (29) thatyields preparations
enriched for the EGF receptor (30). They were treated briefly with nucleases as
for two-dimensionalgel electrophoresis (16, 28), but the lyophilizedsamples were
dissolved in electrophoresis sample buffer (see below) and run on a 15% acryl-
amide/0.087% bisacrylamide gel. For in vitro phosphorylation, membranes from
-8 x 105 unlabeled A431 cells were suspended in 5 pl of 10 mM 4-(2-hydroxy-
ethyl)-1-piperazineethanesulphonate, pH 7.4, and incubated with 5 frl of20mM
PIPES, 10mM MnClz, pH 7.0, containing 0 or 5 ng of EGF and 250 ng of serum
albumin, at 0°C for 10 min. Then 5 11Ci of [y_32P]ATP (Amersham Corp.,
Arlington Heights, Ill . ; 3,000 Ci/mmol) in 5 Al ofthe PIPES, MnC12 buffer were
added . After 10 min at 0°C, the samples were adjusted to contain2% SDS, 5%
2-mercaptoethanol, 50mM Tris,pH 6.8, and 10% glycerol, and one third ofthe
reaction was analyzed by electrophoresis. Coomassie Blue staining showed pro-
teins seen before in well-characterized membrane preparations (31) .
Purification and peptide mapping of the36K phosphoprotein from dishes of
1.3 x 105 cells labeled with 7.5 mCi of'`P were described before (l7) .
RESULTS
Isolation and Characterization of RSV-infected
A431 Cells
A431 cells were infected with RSV and cloned in soft agar.
Four colonies were successfully grown and tested for pp60s"
protein kinase activity. pp60s" was precipitated from cell ex-
tracts with serum from a rabbit bearing RSV-induced tumors,
and transfer of phosphate to the immunoglobulin was used as
a measure of protein kinase activity (25) . The serum used
precipitates the cellular homologue, pp60`
-
s", inefficiently . On
the basis of this assay, one cell clone contained high pp60 ...
activity (Table I, clone 6), another had somewhat less (clone
7), and two had none (clone 11 and one other clone not shown) .
Upon precipitation of [ 355]methionine-labeled extracts, a
TABLE I
Immune Complex Kinase Activity of Transformed A431 Cells
cpm incorporated*
Non-
immune Immune
Cell line
￿
serum
￿
serum
A431
￿
26
￿
45
SRA431, clone 6
￿
23
￿
1,423
SRA431, clone 7
￿
23
￿
1,121
SRA431, clone 11
￿
24
￿
48
SR3T3 (P1A5) f
￿
23
￿
841
SRA431, clone 6
Control§
￿
35 1,152
+ EGF
￿
38
￿
1,124
* Immune complex kinase activity was measured . See Materials and Methods .
$Mouse 3T3 cells transformed with the same RSV used to infect SRA431 cells
(gift of T . Patschinsky) . The parental 3T3 cells have control levels of immune
complex kinase activity .
§ In a separate experiment, cells were incubated with 0 or 10 nM EGF for 1 h
before immunoprecipitation .
60,000 mol wt protein was readily detected in SRA431 clone 6
cells but not in uninfected controls (not shown) . One-dimen-
sional peptide mapping of the 35S-labeled protein showed that
partial Staphylococcal protease cleavage yields two major frag-
ments characteristic of pp60s" (32) and different from those of
pp60`-" . We concluded that we had obtained at least one clone
of A431 cells containing an active viral pp60-`. We will refer
to this clone as "infected" rather than "transformed," since the
parental cells are by definition already transformed, being
established from a tumor.
The infected cells also contained the RSV structural protein
precursor, Pr769'9 , but the mature structural proteins were not
detected . Culture fluids from SRA431 clone 6 cells were not
infectious for chicken cells, in accord with the block in virus
production found in other RSV-transformed mammalian cells
(23, 33) . In terms of morphology and growth rate in liquid
culture, the infected cells were not significantly different from
the parental A431 cells .
The number of specific EGF binding sites on SRA431 cells
were estimated by standard procedures (26) . We found 7 x 106
saturable EGF binding sites per A431 cell, in general agree-
ment with published values (27), whereas there were 14 x 106
sites per SRA431 (clone 6) cell . We suspect that this difference
is not because the SRA431 cells were infected but rather
because the A431 cells used to derive the infected lines, and for
control experiments, had not been cloned . Transformation by
RSV does not inhibit EGF binding to mouse fibroblasts (34) .
Both the infected and control A431 cells respond to the
addition ofEGF by rounding and by adhering less well to the
substrate (35, and our data not shown) . EGF is not mitogenic
for A431 cells . On the contrary, recent reports (36, and Gill, G .
N ., and C . S . Lazar, manuscript submitted for publication .)
have shown that low concentrations ofEGF arrest the growth
of A431 cells . We have repeated this observation with A431
cells and find that EGF also inhibits the growth of SRA431
cells (data not shown) and even appeared to be toxic .
Phosphoproteins of SRA431 Cells
The proteins of mammalian and avian cells transformed by
RSV contain more phosphotyrosine than do the proteins of
control cells (11). However, since the phosphotyrosine level in
uninfected A431 cells is higher than in most nontransformed
cells or other human tumor lines (15), there is only a small
increase in level in the infected cells (Table II) .
When A431 cells are treated with 10 nM EGF, the phospho-
tyrosine content of cell proteins quadruples within 1 min (15) .
A431
SRA431 (clone 6)
TABLE II
Phosphoamino Acid Analysis of Cellular Proteins
Relative proportion*
Phos-
Phos- pho- Phos-
photyro- threo- pho-
Cells
￿
EGF sine nine serine
nM
0 0.18 8.04 91 .78
10 0.70 7.12 92.18
0 0.22 7.44 92.34
10 0.97 8.10 90.92
The radioactivity in each is expressed as a percentage of the total radioac-
tivity in the three phosphoamino acids (11) . The cells used were sister
cultures of those prepared for the two-dimensional gels shown (Fig . 2) .
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fold to fivefold increase in cellular phosphotyrosine, with the
total level in stimulated SRA43l cells being higher than in
stimulated A431 cells (Table II) .
When SRA43l cells were incubated with asP and analyzed
by two-dimensional gel electrophoresis, the 36K phosphopro-
tein was detected even in the absence of EGF (Fig. 1) . The
extent ofphosphorylation depended on the particular clone of
transformed A431 cells, being greater for the clone that had
the highest pp60 8" kinase activity when assayed in vitro (Table
I). Thus, in human epidermoid cells, as well as a variety of
other cells (16-20), transformation by RSV induces phospho-
rylation of a 36K cellular protein. The 81K phosphoprotein
was not detected in any of the clones of infected A431 cells
(Fig . 1) .
Treatment of SRA43l cells with EGF induces increased
phosphorylation of a number of proteins (some of which are
indicated in Fig . 2D) . Not all of these changes were found in
every experiment; however, when a particular phosphoprotein
was found at increased levels in EGF-treated SRA43l cells, it
was also found in parallel cultures of EGF-treated A431 cells
(Fig . 2B) . Increased phosphorylation of two SRA43l cell
proteins was detected afterEGF treatment in every experiment .
These were the 36K and81K phosphoproteins observed before
(15 ; Fig. 2B and D, large arrowheads) .
Increased phosphorylation ofSRA43l cell 36K protein after
EGF treatment was also detected by two-dimensional gel
electrophoresis of proteins labeled with [ 35S]methionine (Fig.
3) . The phosphorylated form of the 36K protein was located
by autoradiography of mixed 32P- and "S-labeled proteins
(Fig . 3A) . The nonphosphorylated form lies beyond the basic
end of the gel, to the right . Since most of the ["S]methionine-
labeled proteins are not phosphoproteins and do not alter in
amount after brief exposure to EGF, it is easy to observe
increased intensity of this spot relative to other spots, implying
FIGURE 1
￿
Phosphoproteins of control and infected A431 cells . Par-
allel cultures of control (A), SRA431 clone 6 (8), clone 7 (C), or
clone 11 (D) cells were labeled for a total of 14 h with [32p]_
orthophosphate . No EGF was added . Cultures were prepared, and
samples equivalent to -3 x 10° cells were analyzed by two-dimen-
sional gel electrophoresis . Alkali-treated gels were exposed for 3-5
d with intensifying screens . The positions of 81K and 36K phospho-
proteins are indicated by arrowheads .
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increased phosphorylation of the 36K protein (Fig . 3B-D) .
Densitometry of autoradiographs of "P-labeled proteins sug-
gested that the final relative level of phosphorylation was
greater with the combined actions of EGF and infection than
with either agent alone. This implies that stimulation of the
EGF-dependent kinase does not interfere with the action of
pp60"', and vice versa. Event though the effect of infection by
RSV was much smaller than that of EGF when measured by
the increment in the cellular level of phosphotyrosine (Table
II), the effect of infection on phosphorylation of the 36K
protein was about double the effect ofEGF alone . Presumably,
the high level of phosphotyrosine in A431 cells is contributed
partly by phosphoproteins that are not detectable, for a variety
of reasons, by the two-dimensional gel procedure (16) .
Infection of A431 cells does not interfere with the EGF-
dependent phosphorylation ofthe 81K protein . The 81K phos-
phoprotein is readily detected at two to three times higher
levels in SRA43l cells than in A431 cells after EGF addition
(Fig . 2), in keeping with the higher EGF binding in these cells .
Phosphorylation of pp60" and of the
EGF Receptor
The RSV transforming protein, pp60', contains phospho-
tyrosine (2), so we tested whetherEGF could induce increased
phosphorylation of pp60"' . We purified pp608" from 32P-la-
beled control and EGF-treated SRA43l cells by immunopre-
cipitation and gel electrophoresis . Similar amounts of radio-
activity were recovered (301 and 225 cpm, respectively) . More-
over, partial proteolysis showed that the distribution of phos-
phate between the N-terminal (phosphoserine) and C-terminal
(phosphotyrosine) regions was unaltered (data not shown) . The
protein kinase activity of pp608" isolated from unlabeled
SRA43l cells was the same whether or not the cells had been
incubated with EGF (Table I).
The EGF receptor of A431 cells is a 150,000-170,000 mol wt
glycoprotein (37-39), containing many phosphorylation sites
in vivo (15), which does not focus on two-dimensional gels,
although it can be purified from "P-labeled A431 cells by
immunoprecipitation and SDS gel electrophoresis . We found
that the receptor contained phosphoserine, phosphothreonine,
and phosphotyrosine residues and that phosphorylation of all
sites in the receptor increased two to three times after EGF
treatment of the cells (15) . To test whether transformation by
RSV affected the phosphorylation of the receptor, we partially
purified membranes from "P-labeled SRA43l cells and sepa-
rated the proteins on SDS gels (Fig. 4) . A phosphoprotein,
containing relatively alkali-stable phosphate, was found that
has the same mobility, on both 15 and 7.5% polyacrylamide
gels, as the major product of in vitro phosphorylation of
membranes prepared from unlabeled A431 cells (Fig . 4A) .
Cohen et al. (38) have shown that this phosphoprotein is the
EGF receptor . Phosphorylation of this membrane protein was
increased two to three times by EGF treatment of A431 or
SRA43l cells (Fig. 4B) .
We were surprised to find that the 155,000 mol wt (155K)
phosphoprotein could also be detected by SDS gel electropho-
resis of total cellular phosphoprotein, provided the gels were
treated with alkali before autoradiography (Fig . 4 C) . This
analysis also showed EGF-dependent phosphorylation of the
receptor. The somewhat greater amount of phosphate in the
EGF receptor of SRA43l cells, relative to A431 cells, may
reflect the higher number of EGF binding sites in the trans-
formed clone .FIGURE 2
￿
Effect of EGF on phosphoproteins of control and infected A431 cells . Parallel cultures of A431 (A and B) and SRA431
clone6 (C and D) cells were labeled for 16 hwith [32P]orthophosphate . EGF (10 nM final concentration) wasadded to oneculture
of each ( B and D) for the final hour of labeling . Cultures were analyzed as before (see Fig . 1) . All exposures were for3 d .
FIGURE 3
￿
Effect of EGFon proteins of control and RSV-infected A431 cells . Parallel cultures of A431 andSRA431 cellswere labeled
with
a2p or [3'S)methionineand treated with EGF. Cultures were lysed and samples analyzed on two-dimensional gels, which were
not incubated in alkali . (A) Extract of 3.35 x 10°
35S_ labeled SRA431 cells (EGF-treated) (3.67 x 10 8 acid-precipitable cpm) mixed
with 3.35 x 10" 32P-labeled SRA431 cells (EGF-treated) . Part of a 48-h autoradiograph is shown . The arrowheads point to the 36K
phosphoprotein, identified by exposing the same gel with aluminum foil blocking the
35S radioactivity (16) . ( B-D) 35S-labeled
cells, gels impregnated with 2,5-diphenyloxazole and exposed so that the product of time exposed (min) and acid-precipitable
cpm loaded was 3 x 10 8 . (B) A431 cells (no EGF) . (C) SRA431 cells (no EGF) . (D) SRA431 cells (10 nM EGF) .
Phosphopeptides of36K phosphoprotein
To examine the possibility that a common kinase phospho-
rylates the 36K protein, we tested whether EGF and RSV
induced phosphorylation of different sites in this protein . The
major phosphopeptides of the mouse 36K protein phosphory-
lated in RSV- or Abelson murine leukemia virus-transformed
cells are quite different from those of the human 36K protein
phosphorylated in response to EGF, even though the two
proteins appear to be quite similar in primary structure (15) .
However, the 36K protein from SRA431 cells contained a
major phosphotyrosine-containing peptide (Fig . 5A) similar in
mobility to that found in 36K protein from EGF-treated A431
cells (15) . Addition ofEGF to SRA431 cells did not induce the
phosphorylation of additional peptides (Fig. 5 B), suggesting
that in these cells RSV and EGF induce phosphorylation of
the same or closely positioned tyrosine residues . Thus, we
cannot exclude the possibility that RSV and EGF both induce
the phosphorylation of the 36K protein by activating a third
tyrosine-specific protein kinase .
DISCUSSION
We have shown that A431 human tumor cells infected with
RSV, and containing a functional pp608" transforming protein,
are able to bind and respond to EGF much as do cells of the
parental line. However, the transformed cells contain the phos-
phorylated form of a 36K protein that is normally detected in
the parental A431 cells only when they are treated with EGF .
Treatment of the infected cells with EGF induces increased
phosphorylation of this 36K protein and of two other proteins,
an 81K protein and the 155K EGF receptor protein . The 81K
protein is not normally phosphorylated in either control or
transformed A431 cells but is phosphorylated after EGF ad-
dition . The EGF receptor is normally phosphorylated in both
cell types, but it is more highly phosphorylated after EGF
addition.
The isolation of A431 cells infected with RSV has enabled
us to examine some questions regarding the modes of action of
pp608" and EGF . Our experiments with in vivo labeling show
that the effects of RSV and of EGF are not competitive,
implying that these agents have different routes of action, or
that steps common to both pathways are not operating at
maximum capacity with either pathway alone . The intriguing
possibility of chains of tyrosine protein kinases, activating each
other in sequence, has recently been raised (40) . The proximal
protein kinase for phosphorylation of the 81K protein could
well be the EGF receptor-associated kinase itself, since
SRA431 cells contain approximately twice as many receptor
molecules and give a 1.5- to 3-fold higher level of phosphory-
RAPID COMMUNICATIONS
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￿
Effect of EGF on membrane phosphoproteins . Duplicate
cultures containing -106 A431 and SRA431 clone6 cellswere labeled
for 14 h with 1.2 mCi/ml of [azP]orthophosphate . EGF was added as
required, and membranes were purified (Materials and Methods) .
(A) Membrane fractions from "P-labeled SRA431 cells, treated in
vivo with 0 or 10 nM EGF, were electrophoresed beside membranes
from unlabeled A431 cells, which had been phosphorylated in vitro
in theabsence or presence of EGF (30 ; Materialsand Methods) . The
gel was autoradiographed for 5 h . ( B) Membrane fractions from 8.3
x 10° A431 cells (C [under control and KOH]) or SRA431 cells
(RSV), labeled and treated with EGF in vivo, were analyzed . The
dried gel was autoradiographed for 18 h (control), then incubated
in alkali (18) and autoradiographed for 40 h (KOH). (C) Complete
cell samples (8 .3 x 103 cells) were analyzed as in B . The molecular
weight scale applies to A ; the gels in Band Cwere electrophoresed
slightly longer .
FIGURE 5
￿
Phosphopeptides of 36K phosphoprotein . Tryptic digests
were analyzed by two-dimensional thin-layer electrophoresis (an-
ode at left) and chromatography, and autoradiographed with inten-
sifying screens . The arrowheads mark the points of sample applica-
tion . The major radioactive spot contains only phosphotyrosine; the
phosphoserine is labile during the preparation for peptide mapping.
(A) 36Kproteinfrom untreated SRA431 cells (80cpm ; 8-d exposure) .
( B) 36K protein from EGF-treated SRA431 cells (240 cpm; 4-d expo-
sure) .
lated 81K protein upon EGF addition than do the control
A431 cells. Clearly, pp608re does not activate this EGF-depend-
ent kinase sinceonlyEGF inducesphosphorylationofthe 81K
protein .TheEGF-dependent kinase does not appear to activate
pp60are, since we have found that the activity of pp60e-sre of
normal A431 cells (data not shown) and the activity and
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phosphorylation of pp60are of SRA431 cells are unaltered by
EGF.
Both systems induce thephosphorylation ofthe36Kprotein,
apparently at a tyrosine in the same tryptic peptide, although
it is possible that this peptide contains more than one tyrosine.
Erikson and Erikson (20) showed that pp60are, purified to
apparent homogeneity, could phosphorylate purified 36K pro-
tein, in vitro, suggesting that pp60are could phosphorylate the
36K protein directly in vivo . However, it is difficult to exclude
the possibility that pp60arecould activate another protein kinase
with specificity for the same tyrosine of the 36K protein . It is
not yet known whether the36Kprotein can be phosphorylated
by theEGF receptor-associated kinase in vitro . The observa-
tion that the receptor-associated kinase can phosphorylate sera
raised against RSV (41, 42), which are also substrates for
pp60are, shows that both kinases can recognize the same sub-
strates .
Both pp60` -ar` and the EGF receptor-associated kinase are
found in membrane preparations of A431 cells (30, 41) . Addi-
tion of EGF and [y-32P]ATP to unlabeled membranes allows
phosphorylation of a protein of 80,000 mol wt (39) ; but this
protein differs from the 81K phosphoprotein observed in vivo
in its mobility on two-dimensional gels (not shown) . Indeed,
this latter phosphoprotein was not detected in membranes
partially purified from 32P-labeled, EGF-treated cells (not
shown) .
Further analysis of this system awaits the identification of
potential intermediary kinases and further characterization of
the substrates . The possible role of the 36K and 81K proteins
in mediating the biological effects ofEGF in other cell types
remains to be explored .
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